Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Plasminogen subcutaneous - Omnio/Liminal BioSciences

Next Previous
Search
Drug Profile

Plasminogen subcutaneous - Omnio/Liminal BioSciences

Alternative Names: Plasminogen (Human) 10; Subcutaneous Plasminogen (Human) 10

Latest Information Update: 18 Nov 2020

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Omnio AB
  • Developer Liminal BioSciences
  • Class Anti-inflammatories; Antifibrotics; Antithrombotics; Beta-globulins; Blood products and substitutes; Proteins
  • Mechanism of Action Fibrinolytic agents; Plasminogen replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Diabetic foot ulcer; Ear disorders
  • No development reported Inflammation

Most Recent Events

  • 18 Nov 2020 Prometic Life Sciences terminates a phase I/IIa trial in Diabetic foot ulcer in Sweden (SC), prior to November 2020 (EudraCT2016-004782-11)
  • 04 Sep 2020 Liminal BioSciences terminates a phase I/II trial in Ear disorders (Tymapnic membrane perforations) in Sweden (SC) (EudraCT2017-002927-68)
  • 28 Dec 2019 No recent reports of development identified for research development in Inflammation in Sweden (Parenteral)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top